Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
Fuente:
arXiv
Saved in:
| Main Authors: | Wang, Sidi, Kidwell, Kelley, Huang, Bo, Roychoudhury, Satrajit |
|---|---|
| Format: | Preprint |
| Published: |
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023)
by: Zhang, Hong, et al.
Published: (2023)
On regional treatment effect assessment using robust MAP priors
by: Zhang, Xin, et al.
Published: (2026)
by: Zhang, Xin, et al.
Published: (2026)
A robust score test in g-computation for covariate adjustment in randomized clinical trials leveraging different variance estimators via influence functions
by: Zhang, Xin, et al.
Published: (2025)
by: Zhang, Xin, et al.
Published: (2025)
Evaluating treatment effects on longitudinal outcomes with attrition due to death: Methods for a two-dimentional estimand with a case study in Quality of Life
by: Reynders, Dries, et al.
Published: (2025)
by: Reynders, Dries, et al.
Published: (2025)
Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)
by: Chassat, Perrine, et al.
Published: (2025)
Index Date Imputation For Survival Outcomes for Externally Controlled Trials
by: Coent, Q. Le, et al.
Published: (2025)
by: Coent, Q. Le, et al.
Published: (2025)
Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
by: Maity, Arnab Kumar, et al.
Published: (2024)
by: Maity, Arnab Kumar, et al.
Published: (2024)
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)
by: Komaki, Moka, et al.
Published: (2025)
SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
by: Yuan, Shijie, et al.
Published: (2025)
by: Yuan, Shijie, et al.
Published: (2025)
Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)
by: Sunami, Hisato, et al.
Published: (2024)
On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
by: Yang, Peng, et al.
Published: (2026)
by: Yang, Peng, et al.
Published: (2026)
Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
by: Benz, Luke, et al.
Published: (2024)
by: Benz, Luke, et al.
Published: (2024)
Estimating Interpretable Heterogeneous Treatment Effect with Causal Subgroup Discovery in Survival Outcomes
by: Bo, Na, et al.
Published: (2024)
by: Bo, Na, et al.
Published: (2024)
Random Effect Restricted Mean Survival Time Model
by: Hanada, Keisuke, et al.
Published: (2024)
by: Hanada, Keisuke, et al.
Published: (2024)
Weighted Conformal Prediction for Survival Analysis under Covariate Shift
by: Shin, Jaeyoung, et al.
Published: (2025)
by: Shin, Jaeyoung, et al.
Published: (2025)
[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
by: Phillips, Rachael V., et al.
Published: (2024)
by: Phillips, Rachael V., et al.
Published: (2024)
E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
by: Sokolova, Alexandra, et al.
Published: (2026)
by: Sokolova, Alexandra, et al.
Published: (2026)
Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
by: Thomas, Owen, et al.
Published: (2024)
by: Thomas, Owen, et al.
Published: (2024)
Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
by: Long, James P., et al.
Published: (2025)
by: Long, James P., et al.
Published: (2025)
Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)
by: Lotspeich, Sarah C., et al.
Published: (2026)
A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
by: Zhang, Cong, et al.
Published: (2026)
by: Zhang, Cong, et al.
Published: (2026)
Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
by: Mao, Guangcai, et al.
Published: (2025)
by: Mao, Guangcai, et al.
Published: (2025)
An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define Ties
by: Cui, Ying, et al.
Published: (2025)
by: Cui, Ying, et al.
Published: (2025)
Backward Joint Model for the Joint Dynamic Prediction of Time-to-Event and Longitudinal Data: Basic Formulation and New Developments
by: Li, Wenhao, et al.
Published: (2023)
by: Li, Wenhao, et al.
Published: (2023)
A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
by: Pramanik, Paramahansa, et al.
Published: (2026)
by: Pramanik, Paramahansa, et al.
Published: (2026)
Simulation-Guided Planning of a Target Trial Emulated Cluster Randomized Trial for Mass Small-Quantity Lipid Nutrient Supplementation Combined with Expanded Program on Immunization in Rural Niger
by: Alam, Shomoita, et al.
Published: (2025)
by: Alam, Shomoita, et al.
Published: (2025)
Distribution-Free Selection of Low-Risk Oncology Patients for Survival Beyond a Time Horizon
by: Sesia, Matteo, et al.
Published: (2025)
by: Sesia, Matteo, et al.
Published: (2025)
Comparing Lasso and Adaptive Lasso in High-Dimensional Data: A Genetic Survival Analysis in Triple-Negative Breast Cancer
by: González-Barquero, Pilar, et al.
Published: (2024)
by: González-Barquero, Pilar, et al.
Published: (2024)
BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)
by: Zhu, Di, et al.
Published: (2026)
Priors from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
by: Ouyang, Yongdong, et al.
Published: (2024)
by: Ouyang, Yongdong, et al.
Published: (2024)
Cure Rate Joint Model for Time-to-Event Data and Longitudinal Tumor Burden with Potential Change Points
by: Qu, Yixiang, et al.
Published: (2025)
by: Qu, Yixiang, et al.
Published: (2025)
Hurdle Network Model With Latent Dynamic Shrinkage For Enhanced Edge Prediction in Zero-Inflated Directed Network Time Series
by: Pramanik, Sandipan, et al.
Published: (2025)
by: Pramanik, Sandipan, et al.
Published: (2025)
Network Meta Analysis of Mean Survival
by: Apsemidis, Anastasios, et al.
Published: (2025)
by: Apsemidis, Anastasios, et al.
Published: (2025)
Stable Survival Extrapolation via Transfer Learning
by: Apsemidis, Anastasios, et al.
Published: (2024)
by: Apsemidis, Anastasios, et al.
Published: (2024)
On Assessing Overall Survival (OS) in Oncology Studies
by: Hsu, Jason C.
Published: (2025)
by: Hsu, Jason C.
Published: (2025)
Multicalibration for Modeling Censored Survival Data with Universal Adaptability
by: Ye, Hanxuan, et al.
Published: (2024)
by: Ye, Hanxuan, et al.
Published: (2024)
Doubly Robust Targeted Estimation of Conditional Average Treatment Effects for Time-to-event Outcomes with Competing Risks
by: Li, Runjia, et al.
Published: (2024)
by: Li, Runjia, et al.
Published: (2024)
Inference on Survival Reliability with Type-I Censored Weibull data
by: Liu, Bowen, et al.
Published: (2026)
by: Liu, Bowen, et al.
Published: (2026)
Weighted Brier Score -- an Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration
by: Zhu, Kehao, et al.
Published: (2024)
by: Zhu, Kehao, et al.
Published: (2024)
Modeling Time-Varying Effects of Mobile Health Interventions Using Longitudinal Functional Data from HeartSteps Micro-Randomized Trial
by: Yu, Jiaxin, et al.
Published: (2024)
by: Yu, Jiaxin, et al.
Published: (2024)
Similar Items
-
Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023) -
On regional treatment effect assessment using robust MAP priors
by: Zhang, Xin, et al.
Published: (2026) -
A robust score test in g-computation for covariate adjustment in randomized clinical trials leveraging different variance estimators via influence functions
by: Zhang, Xin, et al.
Published: (2025) -
Evaluating treatment effects on longitudinal outcomes with attrition due to death: Methods for a two-dimentional estimand with a case study in Quality of Life
by: Reynders, Dries, et al.
Published: (2025) -
Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)